Sensitization of (colon) cancer cells to death receptor related therapies-Reference-Cited by-同舟云学术

Sensitization of (colon) cancer cells to death receptor related therapies

Published:2012-05 Issue:7 Volume:13 Page:458-466
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Pintzas Alexander,Zhivotovsky Boris,Workman Paul,Clarke Paul A.,Linardopoulos Spiros,Martinou Jean-Claude,Lacal Juan Carlos,Robine Sylvie,Nasioulas George,Andera Ladislav

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.4161/cbt.19600

Reference60 articles.

1. Apoptotic Pathways and Therapy Resistance in Human Malignancies

2. Colorectal cancer

3. Mutations of the BRAF gene in human cancer

4. Targeting the Mitogen-Activated Protein Kinase Pathway: Physiological Feedback and Drug Response: Fig. 1.

5. Drugging the PI3 Kinome: From Chemical Tools to Drugs in the Clinic

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the death receptor signaling pathway as a potential therapeutic target in the treatment of colorectal cancer;Journal of Cellular Physiology;2018-05-09

2. The probiotic Propionibacterium freudenreichii as a new adjuvant for TRAIL-based therapy in colorectal cancer;Oncotarget;2016-01-11

3. The DeISGylase USP18 limits TRAIL-induced apoptosis through the regulation of TRAIL levels;Cancer Biology & Therapy;2013-12

4. Upregulation of c-FLIP-short in response to TRAIL promotes survival of NSCLC cells, which could be suppressed by inhibition of Ca2+/calmodulin signaling;Cell Death & Disease;2013-03